Company Overview and News


Add 533288
to your dashboard

Headline News

Claris Lifesciences rises 3% as RBI allows FPIs to raise stake to 49%

2017-10-18 moneycontrol
Claris Lifesciences share price gained 2.6 percent intraday Wednesday after the Reserve Bank of India has allowed foreign investors to raise their stake in the company to 49 percent.

RBI hikes Claris Lifesciences FPI investment limit to 49%; NRI limit at 24%

2017-10-18 indiainfoline
Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) investment limit under Portfolio Investment Scheme in Claris Lifesciences Ltd has increased from 24%to 49% of its paid-up capital," the RBI said in a notification

Market Live: Sensex extends losses at open, Nifty holds 10,200; Axis Bank tanks 7%

2017-10-18 moneycontrol
10:00 am Listing: MAS Financial Services share price started off trade with a whopping premium of 44 percent on the National Stock Exchange. (25-0)

FII Investment under PIS.

2017-10-17 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication. (4-0)

Claris Lifesciences net cash stands at Rs 381 per share, stock down 7.46%

2017-10-12 moneycontrol
Drug maker Claris Lifesciences said its net cash availability stands at Rs 2077 crore translating to Rs 381 per every single share, without considering taxes.

Claris studying options to distribute Rs 2,077 cr to its shareholders

2017-10-12 business-standard
Ahmedabad-headquartered Claris Lifesciences that recently completed the sale of its remaining 20 per cent stake in Otsuka Pharmaceutical India Private Limited (OPIPL), the joint venture with Otsuka Pharmaceutical Factory and Mitsui & Co, to Otsuka, on Thursday said that it is considering options (dividend or share buyback) to distribute around Rs 2,077 crore to its shareholders.   In a filing to the BSE, Claris Lifesciences said that the total cash available with the company is Rs 3,614 crore.

Late rally lifts Sensex 348 pts; Nifty tad below 10,100; RIL up 4% ahead of Q2 nos

2017-10-12 moneycontrol
It was a spectacular rally in late trade Thursday as the Sensex surged 375 points and the Nifty reclaimed 10,100 level intraday, backed by Reliance Industries, private banks, FMCG and metals stocks. The broader markets also participated in the rally, rising for the second consecutive session. (9-0)

Claris Lifesciences transaction raises investor concerns

2017-10-12 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.

Claris completes sale of its remaining 20% stake in Otsuka JV for Rs 130 cr

2017-09-22 business-standard
Ahmedabad-headquartered injectables player Claris Lifesciences has completed the sale of its remaining 20 per cent stake in Otsuka Pharmaceutical India Private Limited (OPIPL), the joint venture with Otsuka Pharmaceutical Factory and Mitsui & Co, to Otsuka for Rs 130 crore ($20 million).

Claris Lifesciences completes sale of its stake in JV to Otsuka

2017-09-21 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.

Carlyle Group merges growth, buyout verticals in India

2017-08-16 livemint
Mumbai: Carlyle Group, a global alternative asset manager with $170 billion of assets under management, is streamlining its operations in India by merging its growth and buyout investment departments as part of an effort to focus on more buyout transactions, according to two people aware of the development.

Top buzzing midcap stocks to trade on August 9

2017-08-09 moneycontrol
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Claris Lifesciences, SRF, Sun Pharmaceutical, JSPL, HDIL, Kaveri Seeds, Nalco, and NMDC.

Claris Lifesciences loses 5% as US FDA issues 18 observations at Ahmedabad plant

2017-08-09 moneycontrol
Claris Lifesciences lost over 5 percent intraday on Wednesday as investors turned cautious regarding observations by US drug regulator.

Claris Lifesciences falls over 3%

2017-08-09 indiainfoline
Pharmaceutical company, Claris Lifesciences tumbled over 3% intraday on Wednesday based on media reports regarding the observations of US drug regulator.

Claris sells global generic injectables business to Baxter for $625 mn

2017-07-28 thehindubusinessline
City-based pharma player, Claris Lifesciences Ltd, said the company has completed the sale of its Global Generic Injectables Business to Baxter International Inc (USA) for an enterprise value of $625 million.

Claris completes injectables biz sale, to inform about transfer to shareholders by Oct

2017-07-27 moneycontrol
Claris Lifesciences on Thursday said it has completed sale of its global generic injectables business to Baxter International for an enterprise value of USD 625 million, or about Rs 4,200 crore.

Claris Lifesciences (₹390.8)

2017-07-27 premium.thehindubusinessline
Buying a house to just rent it out may not be a lucrative option in India, shows study of data provided by JLL India. Average rental yields were 3.1 per cent, as of May 2017, for top six cities in... »

U.S. FTC approves Baxter's acquisition of Claris business with condition

2017-07-20 reuters
WASHINGTON (Reuters) - Baxter International Inc (BAX.N) and Claris Lifesciences Ltd (CLAI.BO) have agreed to divest two types of pharmaceutical products to settle U.S. Federal Trade Commission charges that Baxter's proposed acquisition of Claris’ injectable drugs business is anticompetitive, the agency said on Thursday.

Global Clinical Nutrition Products - Consumer Healthcare

2017-07-13 prnewswire
LONDON, July 12, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million. The Global market is analyzed by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition.

Baxter (BAX) Scales 52-Week High: What's Behind the Rally

2017-06-22 zacks
Share price of Deerfield, IL-based Baxter International Inc. (BAX - Free Report) scaled a new 52-week high of $60.47 on Jun 21, closing a bit lower at $60.05. The company has gained around 3.68% over the past month, much better than the S&P 500’s addition of 1.98%.

Not received any observation from USFDA audit: Claris

2017-06-01 thehindubusinessline
Claris Lifesciences underwent an audit by the USFDA for pharmacovigilance in the last week of May and has not received any observation.

Claris Life gets healthier after USFDAs successful audit

2017-06-01 indiainfoline
Claris Lifesciences gained 1.97% to Rs 333.50 at 11:15 IST on BSE after the company announced that it underwent a successful USFDA Pharmacovigilance audit.

Market Live: Sensex, Nifty trade in a narrow range; Maruti falls on weak auto sales

2017-06-01 moneycontrol
11:50 am Escorts at record high: Escorts said its agri machinery segment in May sold 6,886 tractors, higher by 29 percent over 5,331 units sold in year-ago month. The growth on month-on-month basis was 41 percent, it added.

Claris Lifesciences soars 12% on successful US FDA audit and no observations

2017-06-01 moneycontrol
Claris Lifesciences zoomed nearly 12 percent intraday on Thursday after investors cheered the positive developments around US FDA inspection.

Baxter International at a 52-Week High on Solid Product Line

2017-05-31 zacks
Share price of Deerfield, IL-based Baxter International Inc. (BAX - Free Report) scaled a new 52-week high of $59.49 on May 30, eventually closing a bit lower at $59.35. The company has gained around 17% over the past three months, much better than the S&P 500’s addition of 3%.